Prolight Diagnostics AB (publ) (NGM:PRLD)
17.60
-0.14 (-0.79%)
At close: Sep 3, 2026
Prolight Diagnostics AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 16.94 | 40.61 | 15.73 | 13.27 | 54.11 | 43.89 |
Cash & Short-Term Investments | 16.94 | 40.61 | 15.73 | 13.27 | 54.11 | 43.89 |
Cash Growth | 199.67% | 158.08% | 18.53% | -75.47% | 23.30% | -14.16% |
Other Receivables | 9.35 | 14.41 | 14.28 | 9.42 | 1.44 | 0.31 |
Receivables | 9.35 | 14.41 | 14.28 | 9.42 | 1.44 | 0.31 |
Prepaid Expenses | 0.1 | 2.79 | 0.1 | 0.16 | 1.29 | 2.06 |
Other Current Assets | - | - | - | - | - | 0 |
Total Current Assets | 26.39 | 57.81 | 30.12 | 22.85 | 56.84 | 46.25 |
Property, Plant & Equipment | 10.3 | 8.24 | 6.5 | 2.69 | 0.7 | - |
Other Intangible Assets | 0.01 | 0.02 | 1.86 | 87.79 | 24.95 | 1.84 |
Long-Term Deferred Charges | 143.32 | 127.28 | 127.86 | 24.7 | 125.43 | 101.04 |
Other Long-Term Assets | - | 0.09 | - | 31.2 | - | - |
Total Assets | 180.03 | 193.43 | 166.33 | 169.23 | 207.91 | 149.13 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 7.99 | 6.35 | 3.79 | 4.18 | 0.99 | 0.9 |
Accrued Expenses | 5.12 | 2.46 | 2.68 | 0.96 | 1.22 | 1.93 |
Other Current Liabilities | 1.34 | 0.85 | 13.79 | 13.32 | 0.29 | - |
Total Current Liabilities | 14.45 | 9.66 | 20.26 | 18.45 | 2.51 | 2.82 |
Other Long-Term Liabilities | 14.42 | 14.42 | 17.79 | 17.79 | - | - |
Total Liabilities | 28.86 | 24.08 | 38.05 | 36.24 | 2.51 | 2.82 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 120.45 | 120.45 | 70.21 | 34.68 | 28.23 | 14.91 |
Additional Paid-In Capital | 279.88 | 279.88 | 237.87 | 237.23 | 195.6 | 125.48 |
Retained Earnings | -249.17 | -49.71 | -26.94 | - | - | 5.92 |
Comprehensive Income & Other | - | -181.27 | -152.86 | -138.92 | -18.43 | 0 |
Shareholders' Equity | 151.16 | 169.35 | 128.29 | 132.99 | 205.41 | 146.31 |
Total Liabilities & Equity | 180.03 | 193.43 | 166.33 | 169.23 | 207.91 | 149.13 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 16.94 | 40.61 | 15.73 | 13.27 | 54.11 | 43.89 |
Net Cash Growth | 199.67% | 158.08% | 18.53% | -75.47% | 23.30% | -14.16% |
Net Cash Per Share | - | 3.42 | 2.66 | 4.69 | - | 29.43 |
Filing Date Shares Outstanding | - | 12.04 | 7.02 | 3.47 | 2.82 | 1.49 |
Total Common Shares Outstanding | - | 12.04 | 7.02 | 3.47 | 2.82 | 1.49 |
Working Capital | 11.95 | 48.14 | 9.86 | 4.41 | 54.33 | 43.43 |
Book Value Per Share | - | 14.06 | 18.27 | 38.35 | 72.77 | 98.13 |
Tangible Book Value | 151.15 | 169.33 | 126.43 | 45.21 | 180.46 | 144.47 |
Tangible Book Value Per Share | - | 14.06 | 18.01 | 13.03 | 63.93 | 96.89 |
Machinery | - | 12.27 | 8.99 | 3.69 | 0.92 | - |